TABLE 4.
Code | Biochemical2 | Superpathway | Subpathway | P value | Fold change3 |
---|---|---|---|---|---|
x40473_6 | Hydantoin-5-propionate | Amino acid | Histidine metabolism | 0.016 | 0.821 |
x57687_6 | N,N,N-Trimethyl-5-aminovalerate | Amino acid | Lysine metabolism | 0.003 | 1.21 |
x541_6 | 4-Hydroxyphenylacetate | Amino acid | Phenylalanine metabolism | 0.028 | 1.23 |
x27672_6 | 3-Indoxyl sulfate | Amino acid | Tryptophan metabolism | 0.015 | 1.30 |
x37092_6 | γ-Glutamyl-2-aminobutyrate | Peptide | γ-Glutamyl amino acid | 0.001 | 1.27 |
x48425_6 | Phenylacetylcarnitine | Peptide | Acetylated peptides | 0.006 | 1.35 |
x35126_6 | Phenylacetylglutamine | Peptide | Acetylated peptides | 0.003 | 1.30 |
x396_6 | Glutarate (C5-DC) | Lipid | Fatty acid dicarboxylate | 0.046 | 1.21 |
x54907_6 | Hexanoylglutamine | Lipid | Fatty acid metabolism (acyl glutamine) | 0.003 | 0.834 |
x40406_6 | Trimethylamine N-oxide | Lipid | Phospholipid metabolism | 0.004 | 1.25 |
x35625_6 | 1-Myristoyl-glycerol | Lipid | Monoacylglycerol | 0.002 | 0.787 |
x32506_6 | 2-Linoleoyl-glycerol | Lipid | Monoacylglycerol | 0.009 | 0.827 |
x54966_6 | Diacylglycerol* | Lipid | Diacylglycerol | 0.014 | 0.816 |
x57373_6 | Palmitoyl-docosahexaenoyl-glycerol* | Lipid | Diacylglycerol | 0.010 | 0.838 |
x37198_6 | 5α-Pregnan-3β,20α-diol disulfate | Lipid | Progestin steroids | 0.000 | 1.33 |
x32425_6 | Dehydroepiandrosterone sulfate (DHEA-S) | Lipid | Androgenic steroids | 0.008 | 1.27 |
x38168_6 | 16α-Hydroxy DHEA 3-sulfate | Lipid | Androgenic steroids | 0.019 | 1.19 |
x63731_6 | Glycoursodeoxycholic acid 3-sulfate | Lipid | Secondary bile acid metabolism | 0.009 | 1.38 |
x601_6 | Dihydroorotate | Nucleotide | Pyrimidine metabolism, orotate containing | 0.006 | 0.818 |
x15753_6 | Hippurate | Xenobiotics | Benzoate metabolism | 0.014 | 1.37 |
x62533_6 | (2,4 or 2,5)-Dimethylphenol sulfate | Xenobiotics | Food component/plant | 0.017 | 0.793 |
x48698_6 | 6-Hydroxyindole sulfate | Xenobiotics | Chemical | 0.025 | 1.32 |
Metabolites with statistically significant P values (P < 0.05) from linear regression models adjusted for baseline measures of the outcome variables and child age and sex, and large-magnitude fold changes (log2 fold change >0.25), which were calculated as the ratio of geometric means. Biochemical compound codes, names, superpathways, and subpathways provided by Metabolon Inc.
An asterisk (*) indicates compounds that have not been officially confirmed based on a standard, but for which Metabolon Inc is confident in the identity.
Fold changes for which the intervention egg group had a higher mean are >1, and fold changes for which the control group had a higher mean are <1.